Related Experiment Video
Updated: Oct 17, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Functional Role of Long Non-Coding RNAs in Melanoma
Michal Wozniak1, Malgorzata Czyz1
1Department of Molecular Biology of Cancer, Medical University of Lodz, 92-215 Lodz, Poland.
Abstract:
Melanoma is the most lethal skin cancer, with increasing incidence worldwide. The molecular events that drive melanoma development and progression have been extensively studied, resulting in significant improvements in diagnostics and therapeutic approaches. However, a high drug resistance to targeted therapies and adverse effects of immunotherapies are still a major challenge in melanoma treatment. Therefore, the elucidation of molecular mechanisms of melanomagenesis and cancer response to treatment is of great importance. Recently, many studies have revealed the close association of long noncoding RNAs (lncRNAs) with the development of many cancers, including melanoma. These RNA molecules are able to regulate a plethora of crucial cellular processes including proliferation, differentiation, migration, invasion and apoptosis through diverse mechanisms, and even slight dysregulation of their expression may lead to tumorigenesis. lncRNAs are able to bind to protein complexes, DNA and RNAs, affecting their stability, activity, and localization. They can also regulate gene expression in the nucleus. Several functions of lncRNAs are context-dependent. This review summarizes current knowledge regarding the involvement of lncRNAs in melanoma. Their possible role as prognostic markers of melanoma response to treatment and in resistance to therapy is also discussed.
Insights
Long noncoding RNAs (lncRNAs) are increasingly linked to melanoma development and treatment resistance. Understanding lncRNA roles is crucial for improving melanoma therapies and patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma incidence is rising globally, posing a significant public health challenge.
- Current melanoma treatments face limitations due to drug resistance and adverse effects.
- Long noncoding RNAs (lncRNAs) are implicated in various cancers, including melanoma.
Purpose of the Study:
- To review the current understanding of lncRNAs in melanoma development and progression.
- To explore the role of lncRNAs in melanoma treatment response and resistance.
- To highlight the potential of lncRNAs as diagnostic and prognostic markers.
Main Methods:
- Literature review of studies investigating lncRNAs in melanoma.
- Analysis of lncRNA mechanisms in cellular processes relevant to cancer.
- Discussion of lncRNA involvement in therapeutic resistance.
Main Results:
- lncRNAs regulate key cellular processes such as proliferation, migration, and apoptosis.
- Dysregulation of lncRNA expression is associated with melanoma tumorigenesis.
- lncRNAs can influence stability, activity, and localization of molecular targets.
Conclusions:
- lncRNAs play a significant role in melanoma pathogenesis.
- lncRNAs show promise as biomarkers for predicting treatment response and resistance.
- Further research into lncRNA functions is essential for advancing melanoma treatment strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Non-LTR Retrotransposons
Types of RNA
RNA Performs Diverse...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

